Intervacc AB (publ), a growth company within veterinary medicine with its vaccine Strangvac® registered in 16 European countries, today announces that Chairman of the Board Håkan Björklund has handed over to ... Read more
Intervacc AB (publ) held its Annual General Meeting (”AGM”) on Wednesday 13 May 2026, at which the following resolutions were made.
Adoption of the income statement and balance ... Read more
The Group in summary
Read moreIntervacc AB (publ), a Swedish growth company in animal health with the vaccine Strangvac® registered on 16 European markets, today announces that the company is strengthening its management team through the ... Read more
Intervacc AB (publ), a Swedish growth company specialising in animal vaccines, highlights the annual initiative Strangles Awareness Week – an international awareness campaign aimed at reducing the spread of strangles ... Read more